Delcath Systems
DCTHDelcath Systems, Inc. Delcath Systems, Inc. (NASDAQ: DCTH) is a publicly traded specialty pharmaceutical and medical device company that develops percutaneous perfusion technologies for the targeted administration of high-dose chemotherapeutic agents to specific organs or regions of the body. Based …
© Wikipedia /
Creative Commons CC-BY-SA 3.0 more at Wikipedia
Insider trades and stock quote 2023-2025
All insider trades at Delcath Systems
Subscribe RSS| Date | Type | Insider | Position | Ø-Price | Volume |
|---|---|---|---|---|---|
| 11/21/2025 | Buy | Sylvester, John Richard | Director | $8.9 | $38,992 |
| 11/11/2025 | Buy | Michel, Gerard J. | CHIEF EXECUTIVE OFFICER | $8.5 | $98,049 |
| 3/19/2024 | Buy | Salamon, Steven A J. | Director | $3.7 | $100,001 |
| 3/19/2024 | Buy | Aharon, Gil | Director | $3.7 | $100,001 |
| 12/12/2023 | Buy | Vukovic, Vojo | Chief Medical Officer | $3.0 | $120,000 |
All information without guarantee! No recommendation/consultation!
© U.S. Securities and Exchange Commission (SEC)